吡格雷联合阿司匹林用于急性心肌梗死的临床疗效

Clinical Efficacy of Pyridine Gray Combined with Aspirin in Acute Myocardial Infarction

目的探究氯吡格雷联合阿司匹林用于急性心肌梗死的临床疗效。方法选取2016年5月至2017年8月武汉市第八医院收治的急性心肌梗死患者200例纳入本次研究,依据不同的治疗方法分为两个组别,甲组采用单一阿司匹林治疗,乙组则在此基础上联用氯吡格雷,比较组间疗效。结果乙组患者的各项临床指标均优于甲组;而并发症发生率更低,治疗总有效率为98.00%,明显高于甲组的84.00%,差异有统计学意义(P<0.05)。结论在急性心肌梗死患者中采用氯吡格雷联合阿司匹林治疗,不仅可以取得良好的疗效,而且能够有效改善患者的临床症状,安全性较高,值得在临床上进一步推广及应用。

Objective To explore the clinical efficacy of clopidogrel combined aspirin for acute myocardial infarction. Methods From May 2016 to August 2017,200 cases of patients with acute myocardial infarction( mi) in this study,based on different methods of treatment is divided into two categories,first using a single aspirin therapy,group b is on the basis of this part with clopidogrel,curative effect between the comparison groups. Results The clinical indexes of group b were superior to that of group a. However,the incidence of complications was lower,and the total effective rate of treatment was 98. 00%,significantly higher than 84. 00% in group a,and the difference was statistically significant( P < 0. 05). Conclusion In patients with acute myocardial infarction with clopidogrel in combination with aspirin treatment,not only can achieve good curative effect,and can effectively improve the patient' s clinical symptoms,high security,is worth further promotion and application in clinic.